ROYAL BANK OF CANADA - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,0000.0%2000.0%0.00%
Q2 2021$1,0000.0%2000.0%0.00%
Q1 2021$1,0000.0%200
-17.4%
0.00%
Q4 2020$1,000
-50.0%
242
-41.1%
0.00%
Q3 2020$2,000
-60.0%
411
-78.0%
0.00%
Q2 2020$5,000
+400.0%
1,864
+527.6%
0.00%
Q1 2020$1,000
-90.9%
297
-89.4%
0.00%
Q4 2019$11,000
-73.2%
2,795
-65.1%
0.00%
Q3 2019$41,000
-14.6%
7,999
+5.0%
0.00%
Q2 2019$48,000
-11.1%
7,618
+0.2%
0.00%
Q1 2019$54,000
-16.9%
7,6000.0%0.00%
Q4 2018$65,000
+1.6%
7,600
+138.1%
0.00%
Q3 2018$64,000
-9.9%
3,192
+17.3%
0.00%
Q2 2018$71,000
+18.3%
2,721
+8.8%
0.00%
Q1 2018$60,000
-31.8%
2,500
-3.0%
0.00%
Q4 2017$88,000
+8.6%
2,577
-32.4%
0.00%
Q3 2017$81,000
-54.2%
3,814
-62.3%
0.00%
Q2 2017$177,000
-5.3%
10,122
-5.2%
0.00%
Q1 2017$187,000
+1000.0%
10,677
+955.0%
0.00%
Q4 2016$17,0001,012
+7684.6%
0.00%
Q4 2015$0
-100.0%
13
-97.1%
0.00%
Q3 2015$8,000
-65.2%
454
-47.5%
0.00%
Q2 2015$23,000864
+6546.2%
0.00%
Q4 2014$0130.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 984,329$6,999,0004.03%
Broadfin Capital, LLC 2,469,894$17,561,0003.63%
Healthcare Value Capital, LLC 100,000$711,0002.74%
ARMISTICE CAPITAL, LLC 2,744,000$19,510,0001.07%
DELTEC ASSET MANAGEMENT LLC 536,836$3,817,0000.84%
SECTORAL ASSET MANAGEMENT INC 808,924$5,751,0000.69%
Mosaic Family Wealth, LLC 91,314$649,0000.26%
Worth Venture Partners, LLC 59,740$425,0000.24%
EMERALD ADVISERS, LLC 626,247$4,453,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 565,319$4,019,0000.16%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders